Medifast, Inc. (MED) — Analysis Summary
Medifast, Inc. (MED) has a market cap of $129.92M with year-over-year revenue growth of -36.0%. Net margin stands at -4.8%. The stock trades at a P/E ratio of -5.1.
Key Takeaways
- Revenue changed -36.0% year-over-year
- Net margin of -4.8%
- P/E ratio of -5.1
Compared to other companies in the MISCELLANEOUS FOOD PREPARATIONS & KINDRED PRODUCTS sector, MED posted revenue growth of -36.0% and trades at a P/E of -5.1.
Medifast, Inc. (MED)
PREVIOUS CLOSE 2026-10-12 · MARKET DATA POLYGON · FINANCIALS SEC EDGAR
Red Flags & WarningsWatch List
Some caution signals are active and should be weighed alongside the valuation work.
Revenue declined 17.8% vs the prior period.
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. The company provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. The company is focused on offering talent to Lifelong Transformation, Making a Healthy Lifestyle Second Nature.
Sector
MISCELLANEOUS FOOD PREPARATIONS & KINDRED PRODUCTS
Employees
380
Headquarters
BALTIMORE, MD
Exchange
XNYS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Annual Dividend/Share
$6.60
Dividend Yield
56.80%
Dividend History
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.